Catalysts for Samson Medical Technologies LLC
17 tracked
Apr 7, 2026
approval
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approval
Samson Medical Technologies LLC
→
Feb 13, 2026
approval
CEFAZOLIN SODIUM — FDA approval
Samson Medical Technologies LLC
→
Dec 1, 2025
approval
CEFAZOLIN SODIUM — FDA approval
Samson Medical Technologies LLC
→
Oct 2, 2025
approval
VANCOMYCIN HYDROCHLORIDE — FDA approval
Samson Medical Technologies LLC
→
Aug 21, 2025
device 510k
Tidal Medical Technologies, LLC — InSee (510k cleared)
Samson Medical Technologies LLC
→
Aug 21, 2025
approval
CEFAZOLIN SODIUM — FDA approval
Samson Medical Technologies LLC
→
Aug 21, 2025
approval
CEFAZOLIN SODIUM — FDA approval
Samson Medical Technologies LLC
→
Aug 21, 2025
approval
CEFAZOLIN SODIUM — FDA approval
Samson Medical Technologies LLC
→
Aug 20, 2025
device 510k
Softac Medical Technologies — EndoFixTissue Fixation System (510k cleared)
Samson Medical Technologies LLC
→
Mar 8, 2024
approval
CEFAZOLIN SODIUM — FDA approval
Samson Medical Technologies LLC
→
May 8, 2023
approval
CEFAZOLIN SODIUM — FDA approval
Samson Medical Technologies LLC
→
Mar 18, 2022
approval
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approval
Samson Medical Technologies LLC
→
Nov 9, 2015
approval
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approval
Samson Medical Technologies LLC
→
Jun 6, 2014
approval
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approval
Samson Medical Technologies LLC
→
Sep 6, 2012
approval
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approval
Samson Medical Technologies LLC
→
May 6, 2010
approval
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approval
Samson Medical Technologies LLC
→
Sep 18, 2001
approval
CEFAZOLIN SODIUM — FDA approval
Samson Medical Technologies LLC
→